Zheng Quan Shi Bao Wang·2025-10-16 01:32Core Insights - In the past five trading days, a total of 97 companies were investigated by institutions, with notable interest in Mindray Medical, Rongbai Technology, and Nengke Technology [1] Group 1: Institutional Research Activity - 80.41% of the companies surveyed were investigated by securities firms, totaling 78 companies [1] - Fund companies conducted research on 65 companies, while private equity firms investigated 41 companies [1] - Among the companies, 26 received attention from more than 20 institutions, with Mindray Medical being the most researched at 184 institutions [1] Group 2: Fund Flows and Stock Performance - In the past five days, three stocks among those with over 20 institutional investigations saw net fund inflows, with Mindray Medical receiving a net inflow of 177 million yuan [1] - Other companies with significant net inflows included Jieli Rigging and Yingxi Network, with inflows of 102 million yuan and 38 million yuan respectively [1] - Of the stocks investigated, seven experienced price increases, with the highest gainers being Sifangda, Jieli Rigging, and Liugong, with increases of 22.55%, 9.09%, and 7.96% respectively [2] Group 3: Company Performance Overview - Mindray Medical's latest closing price was 230.50 yuan, with a decline of 6.18% [3] - Rongbai Technology closed at 28.23 yuan, down 11.73% [3] - Nengke Technology's latest price was 45.72 yuan, reflecting a decrease of 4.97% [3] - The highest net profit growth among companies that have released their Q3 reports was seen in Juzan Optoelectronics, with an increase of 8.43% year-on-year [2]